The Company is subject to United States federal income taxes at an approximate rate of 35%. The reconciliation of the provision for income taxes at the United States federal statutory rate compared to the Companys income tax expense as reported is as follows:
| November 30, 2016 |
November 30, 2015 |
|||||||
| Income tax expense at statutory rate | $ | 16,000 | $ | 14,900 | ||||
| Change in valuation allowance | (16,000 | ) | (14,900 | ) | ||||
| Provision for income taxes | $ | - | $ | - | ||||
Significant components of the Companys deferred tax assets and liabilities as at November 30, 2016 after applying enacted corporate income tax rates, are as follows:
| November 30, 2016 |
November 30, 2015 |
|||||||
| Net operating loss carry forwards | $ | (29,150 | ) | $ | (13,150 | ) | ||
| Less: Valuation allowance | 29,150 | 13,150 | ||||||
| Net deferred tax asset | $ | - | $ | - | ||||
As of November 30, 2016, the Company has unused net operating loss carry-forwards of $93,166 which will begin to expire in twenty years after incurred. The Company provided a full valuation allowance to the deferred tax asset as of November 30, 2016 because it is not presently known whether future taxable income will be sufficient to utilize the loss carry-forwards.